Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Diagnostic test, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:
• Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
• Age ≥40 years
• Pre-existing or newly diagnosed hypertension
• Informed consent from the patient or legal representative
Locations
Other Locations
Finland
Kanta-Häme Central Hospital
RECRUITING
Hämeenlinna
Helsinki University Hospital
RECRUITING
Helsinki
Hyvinkää Hospital
RECRUITING
Hyvinkää
Päijät-Häme Central Hospital
RECRUITING
Lahti
Contact Information
Primary
Tuomas Lumikari, MD
tuomas.lumikari@helsinki.fi
+35894711
Backup
Anu Eräkanto
anu.erakanto@hus.fi
Time Frame
Start Date: 2018-10-17
Estimated Completion Date: 2028-09
Participants
Target number of participants: 405
Treatments
Experimental: Intervention
No_intervention: Control
Standard diagnostic work-up, follow-up, and treatment of hypertension.
Related Therapeutic Areas
Sponsors
Leads: Jukka Putaala